IL4 and Alzheimer disease: Dupilumab is a human monoclonal antibody that targets the interleukin 4 receptor-alpha (IL-4Rα) subunit shared by both interleukin 4 (IL-4) and IL-13 which are key cytokines in the pathogenesis of AD.